Percutaneous closure of patent foramen ovale: safe and effective but underutilized.

Nietlispach, Fabian; Meier, Bernhard (2015). Percutaneous closure of patent foramen ovale: safe and effective but underutilized. Expert review of cardiovascular therapy, 13(2), pp. 121-123. Taylor & Francis 10.1586/14779072.2015.1000305

Text 14779072.2015.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (305kB) | Request a copy

With three recently published randomized trials on patent foramen ovale (PFO) closure, the concept of PFO closure to reduce recurrent strokes has been proven; however, PFO closure is currently only considered for secondary prevention. Given the potential devastating consequences of a PFO-related event, we advocate screening for and closure of a PFO for primary prevention in high-risk populations. Such populations include patients who are suffering from a disease that is associated with PFO (e.g., migraine) or patients with high-risk hobbies/professions (e.g., weight-lifters, frequent-flyers, and deep sea divers). Looking at young people with a remaining average life expectancy of 50 years, we have to close 2.4 PFOs to prevent one stroke. This should support a more proactive attitude toward PFO screening and closure.

Interest & Impact

Downloads

1 since deposited on 06 Mar 2015
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item